AFP and hepatocellular carcinoma: However, these methods show limitations in diagnostic accuracy and sensitivity for early-stage HCC (BCLC 0/A), including approximately 50% sensitivity for AFP and 45% for US alone, even though the sensitivity of combining AFC and US is only 63% [10–12].